Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects

Journal of Korean Medical Science

Volumn 28, Issue 3, 2013, Pages 409-414

  Park, Hyo Eun ^a   Heo, Nam Ju ^a   Kim, Minkyung ^a   Choi, Su Yeon ^a  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Coronary artery; Microalbuminuria; Tomography; X Ray computed

Indexed keywords

CALCIUM; CREATININE;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; FEMALE; HUMAN; MALE; MICROALBUMINURIA; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SEX DIFFERENCE; URINE;

CORONARY ARTERY; MICROALBUMINURIA; TOMOGRAPHY, X-RAY COMPUTED;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; BLOOD PRESSURE; CALCIUM; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84875793348     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.3.409     Document Type: Article

References (27)

1. Van der Tol A, Van Biesen W, De Groote G, Verbeke P, Vermeiren F, Eeckhaut K, Vanholder R. Microalbuminuria is more consistent in the presence of cardiovascular risk factors. J Nephrol 2012. doi: 10.5301/ jn.5000194.
2. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 157: 1413-8.
3. Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol 1992; 37: 345-50.
4. Kang DG, Jeong MH, Lim SY, Yun KH, Kim KH, Lee SH, Lee YS, Hong YJ, Park HW, Kim JH, et al. The relationship between microalbuminuria and coronary artery stenosis or inflammatory markers in patients with angina pectoris. Korean Circ J 2005; 35: 49-54.
5. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
6. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed- Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32: 219-26.
7. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107-12.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
9. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-6.
10. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-75.
11. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Lond) 1995; 88: 629-33.
12. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997; 20: 516-9.
13. Chaiken RL, Khawaja R, Bard M, Eckert-Norton M, Banerji MA, Lebovitz HE. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 1997; 20: 709-13.
14. Vestbo E, Damsgaard EM, Frøland A, Mogensen CE. Urinary albumin excretion in a population based cohort. Diabet Med 1995; 12: 488-93.
15. Tichet J, Vol S, Hallab M, Caces E, Marre M. Epidemiology of microalbuminuria in a French population. J Diabetes Complications 1994; 8: 174-5.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.
18. DeFilippis AP, Kramer HJ, Katz R, Wong ND, Bertoni AG, Carr J, Budoff MJ, Blumenthal RS, Nasir K. Association between coronary artery calcification progression and microalbuminuria: the MESA Study. JACC Cardiovasc Imaging 2010; 3: 595-604.
19. Shastri S, Katz R, Shlipak MG, Kestenbaum B, Peralta CA, Kramer H, Jacobs DR Jr, de Boer IH, Cushman M, Siscovick D, et al. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi- Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2011; 57: 832-40.
20. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-9.
21. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med 2012; 172: 761-9.
22. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998; 47: 793-800.
23. Park IS, Rho TH, Park JW, Jeon DS, Yoon HJ, Choi EJ, Bang BK, Hong SJ. Prevalence of urinary microalbuminuria in normal and hypertensive Koreans and its correlation with blood pressure measured by 24 hours ambulatory blood pressure monitoring. Korean Circ J 1994; 24: 834-40.
24. Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998; 54: 203-9.
25. Deckert T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria. Implications for micro- and macrovascular disease. Diabetes Care 1992; 15: 1181-91.
26. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC. Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 1992; 42: 1160-8.
27. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-22.